Prevalence and Molecular Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Broiler Chickens, Morocco.

IF 0.7 4区 医学 Q4 MEDICAL LABORATORY TECHNOLOGY
Mohamed Amzil, Kaotar Nayme, Abdelwahid Assaidi, Mohammed Timinouni, Asmaa Dihmane, Abouddihaj Barguigua, Aboubakr Khazaz, Omar Charafeddine, Ahmed A Bousfiha, Assiya El Kettani
{"title":"Prevalence and Molecular Profile of Extended-Spectrum β-Lactamase-Producing Escherichia coli in Broiler Chickens, Morocco.","authors":"Mohamed Amzil, Kaotar Nayme, Abdelwahid Assaidi, Mohammed Timinouni, Asmaa Dihmane, Abouddihaj Barguigua, Aboubakr Khazaz, Omar Charafeddine, Ahmed A Bousfiha, Assiya El Kettani","doi":"10.7754/Clin.Lab.2024.240804","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The prevalence, the characterization of extended-spectrum β-lactamase (ESBL)-producing Esche-richia coli (E. coli) strains isolated from broiler chickens in the Casablanca-Settat region of Morocco, and their susceptibility to antibiotics were investigated.</p><p><strong>Methods: </strong>A total of 216 intestinal samples were collected (100 samples in 2017 and 116 samples in 2019). E. coli isolates were screened for reduced susceptibility to Ceftazidime (CAZ) and subjected to antibiotic susceptibility testing. ESBL production was confirmed phenotypically and genotypically using PCR to detect blaTEM, blaCTX-M1, and blaSHV genes.</p><p><strong>Results: </strong>Results revealed a high prevalence (83.5%) of E. coli, with a significant decrease in prevalence observed in 2019 compared to 2017 (69%). Reduced susceptibility to Ceftazidime assay showed that 37% (n = 66) of the 178 E. coli isolates were resistant to Ceftazidime (CAZ-R), which indicates the potential likelihood of having ESBL. ESBL phenotypic testing showed a prevalence of 10.32%, with a slight increase in 2019 (11.5%), compared to 2017 (9%, p > 0.05). Antibiotic susceptibility testing demonstrated high resistance levels, notably in 2019, observed for Amoxicillin (94%), Ceftazidime (81%), and Aztreonam (69%). Multidrug resistance (MDR) significantly increased from 2017 to 2019, with 93% of isolates tested in 2019 resistant to at least three antibiotic families. Genotypic analysis revealed the presence of the blaCTX-M15 (n = 1) and blaTEM1 (n = 2) genes in 2017, with an increase of blaTEM1 in 2019 (n = 9).</p><p><strong>Conclusions: </strong>These findings highlight the emergence and the increases of ESBL-producing E. coli strains in Moroccan broiler chickens, signaling a growing concern for antimicrobial resistance in poultry farming. Enhanced surveillance and control measures are imperative to mitigate the spread of resistant pathogens in both animal and human populations.</p>","PeriodicalId":10384,"journal":{"name":"Clinical laboratory","volume":"71 6","pages":""},"PeriodicalIF":0.7000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical laboratory","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7754/Clin.Lab.2024.240804","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The prevalence, the characterization of extended-spectrum β-lactamase (ESBL)-producing Esche-richia coli (E. coli) strains isolated from broiler chickens in the Casablanca-Settat region of Morocco, and their susceptibility to antibiotics were investigated.

Methods: A total of 216 intestinal samples were collected (100 samples in 2017 and 116 samples in 2019). E. coli isolates were screened for reduced susceptibility to Ceftazidime (CAZ) and subjected to antibiotic susceptibility testing. ESBL production was confirmed phenotypically and genotypically using PCR to detect blaTEM, blaCTX-M1, and blaSHV genes.

Results: Results revealed a high prevalence (83.5%) of E. coli, with a significant decrease in prevalence observed in 2019 compared to 2017 (69%). Reduced susceptibility to Ceftazidime assay showed that 37% (n = 66) of the 178 E. coli isolates were resistant to Ceftazidime (CAZ-R), which indicates the potential likelihood of having ESBL. ESBL phenotypic testing showed a prevalence of 10.32%, with a slight increase in 2019 (11.5%), compared to 2017 (9%, p > 0.05). Antibiotic susceptibility testing demonstrated high resistance levels, notably in 2019, observed for Amoxicillin (94%), Ceftazidime (81%), and Aztreonam (69%). Multidrug resistance (MDR) significantly increased from 2017 to 2019, with 93% of isolates tested in 2019 resistant to at least three antibiotic families. Genotypic analysis revealed the presence of the blaCTX-M15 (n = 1) and blaTEM1 (n = 2) genes in 2017, with an increase of blaTEM1 in 2019 (n = 9).

Conclusions: These findings highlight the emergence and the increases of ESBL-producing E. coli strains in Moroccan broiler chickens, signaling a growing concern for antimicrobial resistance in poultry farming. Enhanced surveillance and control measures are imperative to mitigate the spread of resistant pathogens in both animal and human populations.

产β-内酰胺酶的广谱大肠杆菌在摩洛哥肉鸡中的流行率和分子特征。
背景:研究了摩洛哥卡萨布兰卡-塞塔特地区肉鸡产β-内酰胺酶(ESBL)的大肠埃希菌(E. coli)的流行、特征及其对抗生素的敏感性。方法:共采集肠道样本216份(2017年100份,2019年116份)。筛选对头孢他啶(CAZ)降低药敏的大肠杆菌分离株,并进行药敏试验。利用PCR检测blaTEM、blaCTX-M1和blaSHV基因,证实了ESBL的产生。结果:结果显示大肠杆菌的患病率很高(83.5%),与2017年(69%)相比,2019年的患病率显着下降。头孢他啶敏感性降低试验结果显示,178株大肠杆菌中有37% (n = 66)对头孢他啶(CAZ-R)耐药,提示可能存在ESBL。ESBL表型检测显示患病率为10.32%,与2017年(9%,p < 0.05)相比,2019年(11.5%)略有上升。抗生素敏感性测试显示,特别是在2019年,阿莫西林(94%)、头孢他啶(81%)和阿唑南(69%)的耐药水平很高。从2017年到2019年,多药耐药性(MDR)显著增加,2019年检测的分离株中有93%对至少三种抗生素家族具有耐药性。基因型分析显示,2017年存在blaCTX-M15 (n = 1)和blaTEM1 (n = 2)基因,2019年blaTEM1基因增加(n = 9)。结论:这些发现突出了摩洛哥肉鸡中产生esbl的大肠杆菌菌株的出现和增加,表明家禽养殖中对抗菌素耐药性的关注日益增加。必须加强监测和控制措施,以减轻耐药病原体在动物和人群中的传播。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical laboratory
Clinical laboratory 医学-医学实验技术
CiteScore
1.50
自引率
0.00%
发文量
494
审稿时长
3 months
期刊介绍: Clinical Laboratory is an international fully peer-reviewed journal covering all aspects of laboratory medicine and transfusion medicine. In addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies. The journal publishes original articles, review articles, posters, short reports, case studies and letters to the editor dealing with 1) the scientific background, implementation and diagnostic significance of laboratory methods employed in hospitals, blood banks and physicians'' offices and with 2) scientific, administrative and clinical aspects of transfusion medicine and 3) in addition to transfusion medicine topics Clinical Laboratory represents submissions concerning tissue transplantation and hematopoietic, cellular and gene therapies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信